ES2058552T3 - N-acetil glucosamina como agente citoprotector. - Google Patents

N-acetil glucosamina como agente citoprotector.

Info

Publication number
ES2058552T3
ES2058552T3 ES89311710T ES89311710T ES2058552T3 ES 2058552 T3 ES2058552 T3 ES 2058552T3 ES 89311710 T ES89311710 T ES 89311710T ES 89311710 T ES89311710 T ES 89311710T ES 2058552 T3 ES2058552 T3 ES 2058552T3
Authority
ES
Spain
Prior art keywords
agent
cytoprotector
acetyl glucosamine
glucosamine
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89311710T
Other languages
English (en)
Inventor
Albert F Burton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Application granted granted Critical
Publication of ES2058552T3 publication Critical patent/ES2058552T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)

Abstract

ESTE INVENTO PERTENECE A UN NUEVO USO DE LA GLUCOSAMINA ACETIL-N COMO UN AGENTE CITOPROTECTOR PARA RESTAURAR LA INTEGRIDAD Y FUNCION NORMAL DE LA MEMBRANA MUCOSA EN UN SER HUMANO.
ES89311710T 1988-11-18 1989-11-13 N-acetil glucosamina como agente citoprotector. Expired - Lifetime ES2058552T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000583439A CA1318592C (en) 1988-11-18 1988-11-18 N-acetyl glucosamine as a cytoprotective agent

Publications (1)

Publication Number Publication Date
ES2058552T3 true ES2058552T3 (es) 1994-11-01

Family

ID=4139122

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89311710T Expired - Lifetime ES2058552T3 (es) 1988-11-18 1989-11-13 N-acetil glucosamina como agente citoprotector.

Country Status (8)

Country Link
EP (1) EP0372730B1 (es)
JP (1) JPH0678235B2 (es)
KR (1) KR0145715B1 (es)
AT (1) ATE92313T1 (es)
AU (1) AU623197B2 (es)
CA (1) CA1318592C (es)
DE (1) DE68908117T2 (es)
ES (1) ES2058552T3 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229374A (en) * 1992-01-28 1993-07-20 Burton Albert F Method for treatment of lower gastrointestinal tract disorders
US5192750A (en) * 1992-01-28 1993-03-09 The University Of British Columbia Method and composition for treatment of food allergy
AU3881493A (en) * 1992-03-19 1993-10-21 University Of British Columbia, The Method and composition for suppression of side effects of anti-inflammatory drugs
AU4055993A (en) * 1992-05-15 1993-12-13 University Of British Columbia, The N-acetyl glucosamine as gastroprotective agent
GB9315846D0 (en) * 1993-07-30 1993-09-15 Isis Innovation Tumour inhibitors
CA2408023C (en) * 2002-10-15 2012-01-03 Purepharm Inc. Glucosamine as a food and beverage additive
CN1533776A (zh) * 2003-03-27 2004-10-06 中国人民解放军第三军医大学 N-乙酰氨基葡萄糖在制备用于治疗病毒或细菌感染所致的局部损伤和全身症状的药物中的应用
CN1210038C (zh) 2003-03-27 2005-07-13 中国人民解放军第三军医大学 N－乙酰氨基葡萄糖在制备用于治疗毒物和药物中毒致脏器损伤的药物中的应用
CN1232257C (zh) * 2003-03-27 2005-12-21 中国人民解放军第三军医大学 N－乙酰氨基葡萄糖在制备治疗和控制物理化学因素致非特异性炎症的药物中的应用
CN1232256C (zh) * 2003-03-27 2005-12-21 中国人民解放军第三军医大学 N－乙酰氨基葡萄糖在制备治疗自身免疫反应所致的局部损伤或全身症状的药物中的应用
US20070197470A1 (en) * 2003-09-17 2007-08-23 Qiwang Xu Use of n-acetyl-d-aminogylcosamine in preparation of drugs for modulating microorganisms on mucous membrane
JP2007506645A (ja) * 2003-09-17 2007-03-22 中国人民解放▲軍▼第三▲軍▼医大学 抗腫瘍および抗転移のための製剤の製造におけるｎ−アセチル−ｄ−グルコサミンの使用
BR0318497A (pt) * 2003-09-18 2006-09-12 Univ Pla 3Rd Military Medical composto de droga antibacteriana compreendendo n-acetil-d-glucosamina
US20100105634A1 (en) * 2007-03-07 2010-04-29 Cargill, Incorporated Use of glucosamine as a mental and physical stress recovery enhancer and a performance enhancer
UA110325C2 (en) * 2009-07-03 2015-12-25 Australian Biomedical Company Pty Ltd Medicinal carbohydrates for treating respiratory conditions
WO2019169496A1 (en) * 2018-03-08 2019-09-12 Purepharm Inc. Methods and compositions for preventing and treating conditions related to alpha-synuclein
KR102629903B1 (ko) * 2019-12-18 2024-02-16 주식회사 글로원 N-아세틸글루코사민 유도체를 유효성분으로 함유하는 주입용 필러 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792346C3 (de) * 1968-08-22 1980-10-23 Rotta Research Laboratorium S.P.A., San Fruttuoso Di Monza, Mailand (Italien) Pharmazeutisches Präparat für die Behandlung von degenerativen Gelenkerkrankungen
US4006224A (en) * 1975-09-29 1977-02-01 Lescarden Ltd. Method and agent for treating inflammatory disorders of the gastrointestinal tract
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
GB8524807D0 (en) * 1985-10-08 1985-11-13 Hendry N G C Tissue growth regulation
DE3602670A1 (de) * 1986-01-29 1987-07-30 Speck Ulrich Verwendung von n-acetylglucosamin zur therapie degenerativer gelenkprozesse und verwandter erkrankungen

Also Published As

Publication number Publication date
JPH0678235B2 (ja) 1994-10-05
AU4536289A (en) 1990-05-24
ATE92313T1 (de) 1993-08-15
CA1318592C (en) 1993-06-01
DE68908117T2 (de) 1993-12-02
KR0145715B1 (ko) 1998-08-17
EP0372730A2 (en) 1990-06-13
AU623197B2 (en) 1992-05-07
KR900007424A (ko) 1990-06-01
DE68908117D1 (de) 1993-09-09
EP0372730A3 (en) 1990-06-20
JPH02237929A (ja) 1990-09-20
EP0372730B1 (en) 1993-08-04

Similar Documents

Publication Publication Date Title
ES2058552T3 (es) N-acetil glucosamina como agente citoprotector.
DE68908857T2 (de) Wasserstoffsuperoxid-sterilisierungsverfahren.
DE3882126T2 (de) Künstliches Beatmungsgerät.
DE68909693D1 (de) Angetriebenes Atemgerät.
DE3667728D1 (de) Schutzvorrichtung fuer den menschlichen koerper.
NL190832C (nl) Tandbehandelingsmiddel met anti-tandsteenwerking.
DE68929551D1 (de) Menschliche DNase
DK90089D0 (da) Hudbehandlingspraeparat
DE68904565D1 (de) Absorptionskoerper.
DE68905423T2 (de) Weichkoerperpuppe.
DE3876288T2 (de) Desinfektions- und sterilisierungsmittel.
ATE12159T1 (de) Desinfektions- und steril isierungszusammensetzung.
KR900007411A (ko) Nb-818의 용이흡수성 약제
DE69017567D1 (de) Katheter zur Messung des Herzausstosses.
DE68913088T2 (de) Faserbehandlungszusammensetzung.
IT1146481B (it) Corpo per appuntare fiori, rami e simili
TR24154A (tr) Stabilize edilmis zere halinde hidrojen peroksit katilma ueruenleri ile bunlarin k
EP0117621A3 (en) Cosmetic
GR3005231T3 (es)
ES1007222Y (es) Punta estimuladora perfeccionada.
BR6800372U (pt) Respirador artificial
ATE96020T1 (de) Hautbehandlungsmittel.
BR8706648A (pt) Cigarro com dispositivo extintor
IT8721929A0 (it) Dispositivo di respirazione e rianimazione neonatale.
BR8306870A (pt) Valvula cardiaca mecanica implantavel em seres humanos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 372730

Country of ref document: ES